NEWPORT BEACH, Calif.--(BUSINESS WIRE)--May 19, 2008--Alliant Insurance Services, one of the nation’s largest specialty insurance brokerage firms, has announced the acquisition of Seattle, Wash.-based ...

CEO Joseph Burnett stated that ClearPoint Neuro ended 2025 on its strongest financial quarter of the year, highlighting "a newly acquired and commercialized neurocritical care product line and genuine ...

ClearPoint Health (“ClearPoint”) is a medical stop-loss captive platform for small and mid-sized employers. ClearPoint’s platform empowers employers and benefit advisors to transition employee health ...

[Audio Gap] comments made on this call may include statements that are forward-looking within the meaning of securities laws. These forward-looking statements may include, without limitation, ...

Combined clearance of the navigation and drug delivery technologies enables Canadian neurosurgery centers to leverage the Company's flagship image-guidance workflow and advances ClearPoint Neuro's ...

William Wood, an analyst from B.Riley Financial, reiterated the Buy rating on ClearPoint Neuro (CLPT – Research Report). The associated price target is $10.00. William Wood’s rating is based on ...

Award-winning PR firm providing strategy, media relations, and marketing communications campaigns to Nonaste SAN DIEGO--(BUSINESS WIRE)--Clearpoint Agency, an award-winning public relations firm, is ...

SAN DIEGO & BOSTON--(BUSINESS WIRE)--Clearpoint Agency, a women-owned, award-winning PR firm with offices in the San Diego and Boston areas, announced today that it has appointed Hilary McCarthy as ...

Announcement is made after successful proof-of-concept trial in a preclinical model of intravenous delivery of large molecule tracers across the blood-brain barrier guided by prototype systems, ...

SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the ...

SOLANA BEACH, CA / ACCESS Newswire / March 17, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the ...